These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18481194)

  • 1. Late gadolinium enhancement in cardiomyopathy.
    Alpendurada F; Pennell DJ
    Int J Cardiovasc Imaging; 2008 Aug; 24(6):613-5. PubMed ID: 18481194
    [No Abstract]   [Full Text] [Related]  

  • 2. Late contrast enhancement by CMR: more than scar?
    van der Wall EE; Bax JJ
    Int J Cardiovasc Imaging; 2008 Aug; 24(6):609-11. PubMed ID: 18431687
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.
    Lopez JE; Yeo K; Caputo G; Buonocore M; Schaefer S
    J Cardiovasc Magn Reson; 2009 Nov; 11(1):46. PubMed ID: 19906310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMR detects subclinical cardiomyopathy in mother-carriers of Duchenne and Becker muscular dystrophy.
    Mavrogeni S; Bratis K; Papavasiliou A; Skouteli E; Karanasios E; Georgakopoulos D; Kolovou G; Papadopoulos G
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):526-8. PubMed ID: 23579015
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
    Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
    Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for CMR.
    Shaw PW; Kramer CM
    J Nucl Cardiol; 2015 Oct; 22(5):968-70. PubMed ID: 26153261
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to evaluate cardiomyopathies by cardiovascular magnetic resonance parametric mapping and late gadolinium enhancement.
    Menghoum N; Vos JL; Pouleur AC; Nijveldt R; Gerber BL
    Eur Heart J Cardiovasc Imaging; 2022 Apr; 23(5):587-589. PubMed ID: 35262680
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of multiparametric CMR in left ventricular hypertrophy.
    Nordin S; Dancy L; Moon JC; Sado DM
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):577-585. PubMed ID: 29500729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies.
    Boban M; Pesa V; Persic V; Zulj M; Malcic I; Beck N; Vcev A
    Med Sci Monit; 2018 Jul; 24():5084-5092. PubMed ID: 30032158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging for characterizing myocardial diseases.
    Saeed M; Liu H; Liang CH; Wilson MW
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1395-1414. PubMed ID: 28364177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.